cycloheximide has been researched along with Granulocytic Leukemia, Chronic in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 7 (77.78) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lin, MF; Mai, WY | 1 |
Belloc, F; Bernard, P; Boisseau, MR; Dumain, P; Lacombe, F; Lopez, F; Reiffers, J | 1 |
Lotem, J; Sachs, L | 1 |
Herwig, S; Ma, Y; Su, Q; Tempst, P; Zhang, W | 1 |
Bertoglio, J; Bréard, J; Issaad, C; Léglise, MC; Pallardy, M; Roger, R; Turhan, AG | 1 |
Ezawa, H; Harigaya, K; Ishii, G; Mikata, A; Nakajima, N | 1 |
Constantinou, A; Grdina, D; Huberman, E; Kiguchi, K | 1 |
Shionoya, S | 1 |
Bankhurst, AD; Cutts, JL; Scallen, TJ; Watson, J | 1 |
9 other study(ies) available for cycloheximide and Granulocytic Leukemia, Chronic
Article | Year |
---|---|
Induction of apoptosis by homoharringtonine in G1 phase human chronic myeloid leukemic cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cycloheximide; Dactinomycin; G1 Phase; Harringtonines; Homoharringtonine; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2005 |
The labelling of proliferating cells by Ki67 and MIB-1 antibodies depends on the binding of a nuclear protein to the DNA.
Topics: Antibodies; Cell Line; Cycloheximide; DNA, Neoplasm; Flow Cytometry; Gene Expression; Humans; Immunoblotting; Ki-67 Antigen; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasm Proteins; Nuclear Proteins; Nucleic Acid Conformation; Protein Conformation; Tumor Cells, Cultured | 1994 |
Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Differentiation; Cycloheximide; Drug Resistance; Genes, myc; Hot Temperature; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mutation; RNA, Messenger; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1993 |
Distinct temporal patterns of defensin mRNA regulation during drug-induced differentiation of human myeloid leukemia cells.
Topics: Acetamides; Biomarkers; Blood Proteins; Cell Differentiation; Cycloheximide; Cytokines; Dactinomycin; Defensins; Dimethyl Sulfoxide; Dimethylformamide; DNA, Complementary; Enzyme Inhibitors; Gene Expression Regulation, Leukemic; Genistein; Granulocyte Colony-Stimulating Factor; Granulocytes; HL-60 Cells; Humans; Interferon-gamma; Isoflavones; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphocytes; Lymphoma, Large B-Cell, Diffuse; Neoplasm Proteins; Recombinant Proteins; RNA Processing, Post-Transcriptional; RNA, Messenger; Tetradecanoylphorbol Acetate; Time Factors; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1996 |
BCR-ABL does not prevent apoptotic death induced by human natural killer or lymphokine-activated killer cells.
Topics: Apoptosis; Camptothecin; Cycloheximide; Cytotoxicity, Immunologic; Dactinomycin; DNA Damage; DNA, Neoplasm; Etoposide; Fusion Proteins, bcr-abl; Hematopoietic Stem Cells; Humans; Hydrogen Peroxide; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Puromycin; Recombinant Fusion Proteins; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1996 |
12-O-tetradecanoylphorbol-13-acetate (TPA) downregulates expression of CD30 in erythroleukemia cell line K562.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Antigens, Neoplasm; Blast Crisis; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Gene Expression Regulation, Leukemic; Half-Life; Humans; Ki-1 Antigen; Leukemia, Erythroblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Nucleic Acid Synthesis Inhibitors; Protein Kinase C; Protein Synthesis Inhibitors; RNA, Messenger; RNA, Neoplasm; Signal Transduction; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1997 |
The effect of topoisomerase inhibitors on the expression of differentiation markers and cell cycle progression in human K-562 leukemia cells.
Topics: Amsacrine; Aphidicolin; Cell Cycle; Cell Differentiation; Cycloheximide; Deoxyadenosines; Dose-Response Relationship, Drug; Etoposide; G2 Phase; Hemoglobins; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanins; Mitosis; Novobiocin; Teniposide; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1992 |
Etoposide inhibition of methylaminoisobutyric acid transport and its recovery in K562 cells.
Topics: Aminoisobutyric Acids; Biological Transport; Cell Division; Cycloheximide; Depression, Chemical; Etoposide; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Sodium; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1991 |
Role of mevalonic acid in the regulation of natural killer cell cytotoxicity.
Topics: Cell Line; Cell Survival; Cells, Cultured; Cholesterol; Cycloheximide; Cytotoxicity, Immunologic; Dactinomycin; Dolichols; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Killer Cells, Natural; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lovastatin; Mevalonic Acid; Sterols | 1989 |